
MorphoSys AG MOR
Annual report 2023
added 12-27-2025
MorphoSys AG Historical Prices 2011-2026 | MOR
Annual Historical Prices MorphoSys AG
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.2 | 7.61 | 9.42 | 28.3 | 35.7 | 25.3 | - | - | - | - | - | - | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 35.7 | 7.61 | 20.8 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
15.9 | $ 16.49 | -0.3 % | $ 3.93 B | ||
|
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
3.22 | $ 3.59 | -1.1 % | $ 1.07 B | ||
|
I-Mab
IMAB
|
0.68 | - | - | $ 866 M | ||
|
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M | ||
|
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M | ||
|
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | ||
|
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | ||
|
Apellis Pharmaceuticals
APLS
|
22 | $ 20.5 | 3.22 % | $ 2.59 B | ||
|
Aptorum Group Limited
APM
|
0.75 | $ 0.81 | -1.57 % | $ 4.42 M | ||
|
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
61.9 | $ 75.14 | -1.82 % | $ 1.45 B | ||
|
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.57 | -3.68 % | $ 401 M | ||
|
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | ||
|
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | ||
|
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | ||
|
AVEO Pharmaceuticals
AVEO
|
3.54 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
174 | $ 163.09 | -0.61 % | $ 8.11 B | ||
|
Champions Oncology
CSBR
|
7.75 | $ 6.0 | - | $ 82 M | ||
|
BridgeBio Pharma
BBIO
|
68.4 | $ 65.5 | -1.57 % | $ 12.5 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | ||
|
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | ||
|
Bellerophon Therapeutics
BLPH
|
8.23 | - | -74.18 % | $ 955 K | ||
|
BioLineRx Ltd.
BLRX
|
2.65 | $ 2.84 | 1.07 % | $ 908 M | ||
|
BioMarin Pharmaceutical
BMRN
|
61 | $ 60.3 | -0.22 % | $ 11.6 B | ||
|
Burford Capital Limited
BUR
|
10.6 | $ 8.34 | -0.48 % | $ 1.36 B | ||
|
Cabaletta Bio
CABA
|
17.5 | $ 3.37 | -1.75 % | $ 3.94 M | ||
|
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
0.6 | $ 3.04 | -5.0 % | $ 1.09 M | ||
|
Galmed Pharmaceuticals Ltd.
GLMD
|
1.34 | $ 0.59 | - | $ 549 K | ||
|
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
5.8 | $ 25.56 | 0.22 % | $ 684 M |